VXRT - Vaxart Inc
IEX Last Trade
0.8736
0.022 2.473%
Share volume: 1,600,564
Last Updated: Fri 30 Aug 2024 09:59:51 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.85
0.02
2.54%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-09 | 2023-03-15 | 2023-05-04 | 2023-08-03 | 2023-11-02 | 2024-03-14 | 2024-05-13 | |
| Total revenue | 0.000 | 0.000 | 22.000 K | 675.000 K | 1.358 M | 2.101 M | 3.245 M | 2.181 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 22.000 K | 675.000 K | 1.358 M | 2.101 M | 3.245 M | 2.181 M | |
| nan% | inf% | 2,968.18% | 101.19% | 54.71% | 54.45% | -32.79% | |||
| Operating expenses | 29.247 M | 29.426 M | 26.906 M | 26.247 M | 24.411 M | 19.923 M | 20.145 M | 26.251 M | |
| Selling general and admin | 9.321 M | 6.960 M | 6.447 M | 6.625 M | 5.598 M | 4.921 M | 5.440 M | 7.238 M | |
| Research and development | 19.926 M | 22.466 M | 20.459 M | 19.622 M | 18.813 M | 15.002 M | 14.705 M | 19.013 M | |
| Total expenses | 29.247 M | 29.426 M | 26.906 M | 26.247 M | 24.411 M | 19.923 M | 20.145 M | 26.251 M | |
| 0.61% | -8.56% | -2.45% | -7.00% | -18.39% | 1.11% | 30.31% | |||
| Operating income | -29.247 M | -29.426 M | -26.884 M | -25.572 M | -23.053 M | -17.822 M | -16.900 M | -24.070 M | |
| Ebit | -29.247 M | -29.426 M | -26.884 M | -25.572 M | -23.053 M | -17.822 M | -16.900 M | -24.070 M | |
| Pretax income | -29.415 M | -29.293 M | -23.902 M | -25.111 M | -22.531 M | -17.361 M | -17.201 M | -24.372 M | |
| -0.41% | -18.40% | 5.06% | -10.27% | -22.95% | -0.92% | 41.69% | |||
| Income tax | 15.000 K | 16.000 K | 16.000 K | 29.000 K | 19.000 K | 39.000 K | 174.000 K | 45.000 K | |
| Net income basic | -29.430 M | -29.309 M | -23.918 M | -25.140 M | -22.550 M | -17.400 M | -17.375 M | -24.417 M | |
| 0.41% | 18.39% | -5.11% | 10.30% | 22.84% | 0.14% | -40.53% | |||
| Net income | -29.430 M | -29.309 M | -23.918 M | -25.140 M | -22.550 M | -17.400 M | -17.375 M | -24.417 M | |
| 0.41% | 18.39% | -5.11% | 10.30% | 22.84% | 0.14% | -40.53% |